An error has been detected in the English version of the article «A guide for the administration of oral antineoplastic in patients with swallowing disorders», published in Farm Hosp. 2021;46(3):126-34:
In Table 1. Line 1 relative to ABIRATERONE film-coated tablets (Zytiga®).
Where it says:
The manufacturer recommends crushing or dissolving the product due to a potential decrease in efficacy.
Have to say:
The manufacturer no recommends crushing or dissolving the product due to a potential decrease in efficacy.